HPR100 Analysis of the Drug Price Level of Anticancer and Rare Disease Drugs After the Implementation of Economic Evaluation Exemption in South Korea

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1230
https://www.valueinhealthjournal.com/article/S1098-3015(22)03435-0/fulltext
Title : HPR100 Analysis of the Drug Price Level of Anticancer and Rare Disease Drugs After the Implementation of Economic Evaluation Exemption in South Korea
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03435-0&doi=10.1016/j.jval.2022.09.1230
First page :
Section Title :
Open access? : No
Section Order : 10778
Categories :
Tags :
Regions :
ViH Article Tags :